BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 506798)

  • 21. [Erythema nodosum in sarcoidosis patients].
    Ozerova LV
    Probl Tuberk; 1993; (6):25-7. PubMed ID: 8290525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphopenia induced by acute bacterial infections in the elderly: a sign of age-related immune dysfunction of major prognostic significance.
    Proust J; Rosenzweig P; Debouzy C; Moulias R
    Gerontology; 1985; 31(3):178-85. PubMed ID: 4018589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Löfgren syndrome: a study of 80 cases].
    Tejera Segura B; Holgado S; Mateo L; Pego-Reigosa JM; Carnicero Iglesias M; Olivé A
    Med Clin (Barc); 2014 Aug; 143(4):166-9. PubMed ID: 24855899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphopenia in Wegener's granulomatosis. A new clinical activity index?
    Izzedine H; Cacoub P; Launay-Vacher V; Bagnis C; Deray G
    Nephron; 2002 Oct; 92(2):466-71. PubMed ID: 12218333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of 94 cases of sarcoidosis with special reference to erythema nodosum].
    Atanes A; de Toro J; Gómez N; Aspe B; Graña J; Burson JM; Galdo F
    Rev Clin Esp; 1992 Jun; 191(2):65-70. PubMed ID: 1502392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
    Ayoub JP; Palmer JL; Huh Y; Cabanillas F; Younes A
    Leuk Lymphoma; 1999 Aug; 34(5-6):519-27. PubMed ID: 10492075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood lymphocytes in sarcoidosis.
    Davies BH; Williams JD; Smith MD; Jones-Williams W; Jones K
    Pathol Res Pract; 1982 Oct; 175(1):97-109. PubMed ID: 6218488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
    Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
    Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subpopulations in sarcoidosis.
    Hedfors E; Holm G; Pettersson D
    Clin Exp Immunol; 1974 Jun; 17(2):219-26. PubMed ID: 4549571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The problem of joint sarcoidosis].
    Pavelka K
    Z Rheumatol; 1979; 38(3-4):90-8. PubMed ID: 442843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term prognosis of pulmonary sarcoidosis. 2. Cardiac sarcoidosis and other extrapulmonary manifestations].
    Vestbo J; Langer SW; Iversen ET; Viskum K
    Ugeskr Laeger; 1995 May; 157(20):2848-50. PubMed ID: 7785100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoid and erythema nodosum arthropathies.
    Pettersson T
    Baillieres Best Pract Res Clin Rheumatol; 2000 Sep; 14(3):461-76. PubMed ID: 10985981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment, course and prognosis of sarcoidosis cases].
    Takada K; Ina Y; Noda M; Morishita M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):92-9. PubMed ID: 2355691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy.
    Crouser ED; Lozanski G; Fox CC; Hauswirth DW; Raveendran R; Julian MW
    Chest; 2010 Jun; 137(6):1432-5. PubMed ID: 20525654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction.
    Laroche A; Alarcon Chinchilla E; Bourgeault E; Doré MA
    J Cutan Med Surg; 2018; 22(6):627-629. PubMed ID: 29772919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fever of unknown origin and isolated noncaseating granuloma of the marrow: could this be sarcoidosis?
    Miller AC; Chacko T; Rashid RM; Ledford DK
    Allergy Asthma Proc; 2007; 28(2):230-5. PubMed ID: 17479610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of studying the cellular immunity in ulcerative lesions of the stomach].
    Uspenskiĭ VM; Baranovskiĭ AIu; Vashchenkov VM
    Ter Arkh; 1989; 61(2):21-3. PubMed ID: 2786263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4 lymphopenia to identify end-of-life metastatic cancer patients.
    Péron J; Cropet C; Tredan O; Bachelot T; Ray-Coquard I; Clapisson G; Chabaud S; Philip I; Borg C; Cassier P; Labidi Galy I; Sebban C; Perol D; Biron P; Caux C; Menetrier-Caux C; Blay JY
    Eur J Cancer; 2013 Mar; 49(5):1080-9. PubMed ID: 23246297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Older sarcoidosis patients: experience of a medical center in Turkey.
    Yanardağ H; Pamuk ON
    South Med J; 2004 May; 97(5):472-4. PubMed ID: 15180023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease.
    Marcoval J; Mañá J; Rubio M
    Clin Exp Dermatol; 2011 Oct; 36(7):739-44. PubMed ID: 21790725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.